Author

Y. Mou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:genetic perturbation / CRISPR· 2 Organism:plant (other)· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Z. Yang· 3 shared C. Liu· 2 shared G. Yang· 2 shared L. Cui· 2 shared M. Duan· 2 shared M. Pan· 2 shared T. Liang· 2 shared W. Zeng· 2 shared

Activity by Year

2024-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Z. Yang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Integrated Analyses of Multi-omic Data Derived from Paired Primary Lung Cancer and Brain Metastasis Reveals the Metabolic Vulnerability as a Novel Therapeutic Target

H. Duan, J. Ren, S. Wei, C. Li, Z. Wang, M. Li, Z. Wei, Z. Yang, Y. Liu, Y. Xie, S. Wu, W. Hu, C. Guo, X. Zhang, L. Liang, , Y. Mou

This study integrates multi-omic data from lung cancer and brain metastases to identify mitochondrial metabolism as a therapeutic target in brain metastases.

Genome Medicine · Nov 26, 2024Peer-reviewedCancer Biology

Association study of Plasmodium falciparum Acetyl-CoA Synthetase Mutations S868G and V949I with antimalarial drugs

W. Zhao, Z. Xiang, W. Zeng, Y. Qin, M. Pan, Y. Wu, M. Duan, Y. Mou, T. Liang, Y. Zhang, C. Liu, X. Tang, Y. Huang, G. Yang, L. Cui, Z. Yang

This study investigates the association of PfACAS mutations S868G and V949I with antimalarial drug resistance using whole-genome sequencing and CRISPR/Cas9-engineered parasites.

bioRxiv · Jul 10, 2024 · PreprintMicrobiology

Acetyl-CoA Synthetase Mutations S868G and V949I Do Not Confer Resistance to Antimalarial Drugs in vitro in Plasmodium falciparum.

W. Zhao, Z. Xiang, W. Zeng, Y. Qin, M. Pan, Y. Wu, M. Duan, Y. Mou, T. Liang, Y. Zhang, C. Liu, X. Tang, Y. Huang, G. Yang, L. Cui, Z. Yang

This study investigates whether mutations in PfACAS confer antimalarial drug resistance by engineering parasite lines with these mutations and testing their drug susceptibility in vitro.

bioRxiv · Jun 3, 2024 · PreprintMicrobiology